Skip to main content
. 2024 Dec 19;7:1673. doi: 10.1038/s42003-024-07364-2

Fig. 1. Characterization of ADSC and EVs.

Fig. 1

The phenotype of amplified ADSC analyzed by flow cytometry before EVs production. Histograms representing the percentage of CD90, CD29, and CD73 mesenchymal markers, and CD34 and CD45 hematopoietic markers (a). After production, EVs concentration, mean, and mode were obtained by nanoparticle tracking analysis (b).